Labelling Requirements.

Overview of TGA Labelling Requirements

  • TGA (Therapeutic Goods Administration) sets out labelling requirements for medicinal products to ensure safety and efficacy.

  • Key legislative documents include:

    • Therapeutic Goods Order No. 69: Dictates necessary contents of labels.

    • Required Advisory Statements: Outlines mandatory warning labels.

General Labelling Requirements

  • All medicinal labels, regardless of classification, must meet specific guidelines:

    • Visibility: Labels must be clearly visible and not obscured.

    • Language: Information must be presented in English.

    • Durability: Labels should withstand environmental factors (e.g., oils) without fading or rubbing off.

    • Legibility: Text must be easily readable, avoiding decorative fonts that compromise clarity.

    • Text Size: Minimum text height of 1.5 mm.

    • Contrast: Characters must strongly contrast with the background to enhance readability.

    • Units of Measurement: Only metric units are permissible; no imperial or non-standard measurements such as teaspoons or fluid ounces.

Retail Sale Product Labelling Requirements

  • Retail sale products (over-the-counter) must contain specific information:

    • Name of Medicine: Must clearly denote the product.

    • Active Ingredients: All active ingredients must be listed clearly.

    • Quantity of Active Ingredients: Should specify the proportions contained.

    • Dosage Form: Indicate if the product is a tablet, capsule, liquid, cream, etc.

    • Package Content: Total amount of medicine in the package.

    • Batch Number: Must be included for tracking purposes.

    • Expiry Date: Indicates the last date the product may be used.

    • Register Number: Must include either AUST-L or AUST-R number for identification.

    • Storage Conditions: Instructions on how to store the product (e.g., refrigeration).

    • Warning Statements: Any relevant warning or advisory information must be present.

Extemporaneously Dispensed Products Labelling Requirements

  • Extemporaneous products are those prepared specifically for individual patients and must include:

    • Name and Form: Indicate the specific medicine and its form.

    • Quantity in Package: Specify how much medicine is dispensed.

    • Ingredient List: List all ingredients in descending order.

    • Patient's Name: Specific to the individual for whom it is prepared.

    • Dispensing Date: When the medicine is provided.

    • Expiry Date: Clearly state that after this date, the product should not be used.

    • Usage Instructions: Detailed instructions on how to use the medicine (e.g., dosage).

    • Practitioner's Details: Name and physical address of the prescribing practitioner for contact.

    • Importance of Ingredient Listing: Ensures the patient is aware of all components, particularly for allergy concerns. This is essential for safety, especially in emergency situations.

    • Name and contact details of prescribing practitioner and dispensary entity

Additional Notes

  • Contact Information: Must be a physical address; phone numbers or emails are insufficient for legal purposes.

  • If the product is dispensed by a different entity than the one that created it, both sets of details must be included.

  • Additional warning statements may be included based on specific patient consultations (e.g., if a product contains a herb known for adverse reactions).

  • Always ensure that relevant storage instructions are also conveyed clearly to ensure the product's integrity.